Moderator: Jay Raman, MD 8:45 am - 9:30 am 9:30 am - 9:45 am Moderator: Necole Streeper, MD 10:00 am - 10:15 am 10:15 am - 10:20 am 10:20 am - 10:35 am 10:35 am - 10:40 am 10:40 am - 10:55 am 10:55 am - 11:00 am Moderators: Daniel Lee, MD, Jeffrey Tomaszewski, MD MP1-01 Comparative Outcomes of Salvage Retzius-sparing Versus Standard Robotic Prostatectomy: An International, Multi-Surgeon Series MP1-02 Does Deferred Prostatectomy for Grade Group 1 and 2 Increase Risk of Adverse Pathology? MP1-03 Factors Associated with Use of Active Surveillance in NCCN Favorable Intermediate-Risk Prostate Cancer Patients Who Received a 17-gene Genomic Prostate Score Result MP1-04 A Review of SpaceOAR Complications and Influential Patient Characteristics MP1-05 Do 5-alpha Reductase Inhibitors Effect the Diagnostic Accuracy of MRI-Fusion Biopsies? MP1-06 Comparing MRI/US Fusion to Standard Prostate Biopsy in Determining Grade Reclassification at Confirmatory Biopsy in a Multi-Institutional Active Surveillance Cohort: A Pennsylvania Urology Regional Collaborative (PURC) Analysis MP1-07 PSA Density is Complementary to Prostate MRI PI-RADS Scoring System for Stratifying Clinically Significant Prostatic Malignancies MP1-08 Sagacity of Same Day Discharge: Incidence and Timing of Postoperative Adverse Events Following Minimally Invasive Urologic Surgery MP1-09 Financial Toxicity of Prostate Cancer Survivorship: A National Cross-Sectional Assessment of Indirect Financial Burden MP1-10 Large Scale Implementation of Opioid Prescription Reduction after Robotic Prostatectomy – 2-Year Evaluation from the Pennsylvania Urologic Regional Collaborative (PURC) MP1-11 Analyzing Recent Medicare Reimbursement Trends in Urology MP1-12 Racial and Stage Disparities in Increased Survival Among Patients with Metastatic Prostate Cancer in the Second-Line Antiandrogen Therapy Era MP1-13 Gleason Upgrading Between Targeted and Systematic Template Biopsy for mpMRI PIRADS 5 Lesions MP1-14 Qualitative Evaluation of Differing Opioid Sparing Protocols Across the Pennsylvania Regional Collaborative: Understanding Barriers and Facilitators MP1-15 Existing Urine Exosome Gene Expression Signature to Assess Upgrade Risk on Radical Prostatectomy (RP) Moderator: Ryan Smith, MD Point Counterpoint: Too Much Emphasis Is Given to the Semen Analysis in the Male Factor Fertility 11:00 am - 11:10 am 11:10 am - 11:20 am 11: 20 am - 11:30 am 11:30 am - 11:50 am 11:50 am - 12:00 pm Moderator: Suzanne Merrill, MD 1:15 pm - 2:00 pm 2:00 pm - 2:15 pm Moderators: Justin Friedlander, MD, Rebecca Zee, MD MP2-01 Ambulatory Percutaneous Nephrolithotomy Performed in a Free-Standing Surgery Center: Outcomes of 1000 Cases MP2-02 Automated Machine Learning Segmentation and Measurement of Urinary Stones on CT Scan MP2-03 Use of Mini sipIT Behavioral Intervention to Increase Fluid Intake in Patients with Kidney Stones MP2-04 Use of Novel Software for Predicting Outcomes Following Percutaneous Nephrolithotomy: A Pilot Study MP2-05 Comparison of Management and Outcomes of Symptomatic Urolithiasis During the COVID-19 Pandemic to a Comparative Cohort MP2-06 Post-Operative Pain and Recovery in Patients with Nephrolithiasis: Results from the Endourological Society TOWER Research Collaborative MP2-07 From Doctor Google to the App Store: Where Stone Patients Get Information MP2-08 Identifying and Evaluating Online Kidney Stone Pain Resources MP2-09 Evaluation of Robotic Versus Open Approaches for Unilateral Ureteral Reimplantation in Pediatric Patients MP2-10 Surgical Correction of True Diphallia in a Newborn Male MP2-11 Implementation of a Pre-operative Testing Algorithm During the Initial COVID-19 Wave at a Rural Tertiary Care Center MP2-12 Provider Compliance and Clinical Outcomes Over Two Years Following Implementation of a Pre-Biopsy Rectal Swab Protocol MP2-13 Moses Technology Improves Efficiency of Laser Lithotripsy for Patients Undergoing Mini-PCNL Moderator: Michel Pontari, MD 2:15 pm - 3:00 pm 3:00 pm - 3:15 pm Moderator: Suzanne Merrill, MD 3:45 pm - 4:30 pm 4:30 pm - 4:45 pm Moderators: Jay Simhan, MD, Marisa Clifton, MD Moderator: Jay Raman, MD 8:30 am - 9:15 am 9:15 am - 9:30 am Moderator: Krishnan Venkatesan, MD 9:45 am - 10:00 am 10:00 am - 10:10 am 10:10 am - 10:25 am 10:25 am - 10:35 am 10:35 am - 10:50 am 10:50 am - 11:00 am Moderators: Ahkil Das, MD, Mikel Gray, PhD, CUNP, Nicolas Ortiz, MD MP3-01 Morbidity of Bladder Outlet Obstruction Treatment Following Radiotherapy for Prostate Cancer MP3-02 Evaluating Patient Priorities in Benign Prostatic Hyperplasia Treatment Using Conjoint Analysis MP3-03 Outcomes of Prostatic Urethral Lift (PUL) are Consistent Across Heterogenous Patient Populations in the Real World MP3-04 Sizeable data for Prostatic Urethral Lift (PUL) in Retention Patients: 12-Month Outcomes from the Large Real-World Study and Urodynamic Results from PULSAR Demonstrate PUL is Safe and Effective MP3-05 Comparison of Rezum versus Urolift in the Management of Benign Prostatic Hypertrophy MP3-06 Bleeding Risk with Aquablation Stratified by Prostate Size: A Single Center Experience MP3-07 Relationship Between Overactive Bladder Symptom Severity and Cystometric Bladder Capacity in Patients with Overactive Bladder MP3-08 Stress Incontinence Outcomes Following Robotic Prostatectomy: Interim Analysis of Novel Pelvic Floor Program MP3-09 Post-Phalloplasty Urinary Function Test: A Novel Outcome Instrument to Capture Urinary Dysfunction and Quality of Life after Phalloplasty MP3-10 Adherence with Imaging and Treatment Recommendations Following Urodynamics Testing in Patients with Neurogenic Bladder MP3-11 The Underachieving Results for Overactive Bladder MP3-12 The Natural History of Urinary Retention following in Patients Admitted to Inpatient Rehabilitation After Acute Neurologic Insult MP3-13 Patient Perceptions of Pelvic Organ Prolapse Education Techniques Moderator: Rena Malik, MD 11:00 am - 11:15 am 11:15 am - 11:30 am 11:30 am - 11:45 am 11:45 am - 12:00 pm Moderators: Michael Pontari, MD 1:15 pm - 1:30 pm 1:30 pm - 1:35 pm 1:35 pm - 1:50 pm 1:50 pm - 2:00 pm Moderators: Thenappan Chandrasekar, MD, Rosalia Viterbo, MD MP4-01 Association of Tumor Size and Surgical Approach with Oncological Outcomes in Patients with Adrenocortical Carcinoma MP4-02 Residual/Upgraded Disease at Time of re-TUR when Bluelight Cystoscopy used as Primary Procedure for Non-Muscle Invasive Bladder Carcinoma MP4-03 Social Factors Influence Treatment Decisions in Node-Positive Non-Metastatic Bladder Cancer MP4-04 Treatment Failure and Disease Progression of Non-Muscle Invasive Bladder Cancer During BCG Shortage MP4-05 Management of Non-Muscle Invasive Bladder Cancer in a Time of BCG Shortage MP4-06 Physicians’ Knowledge About Pembrolizumab for High-Risk Non-Muscle Invasive Bladder Cancer: Quality Improvement Targets in Multidisciplinary Cancer Care MP4-07 Robotic-Assisted Laparoscopic Approach to Radical Cystectomy Mitigates Surgical Complications in Patients with Preoperative Malnutrition MP4-08 Rising Rates of Newly Diagnosed Testicular Cancer: 27-Year Trends from a Statewide Registry MP4-09 Urological Management of Incarcerated Persons with Testicular Malignancy at a Single Institution MP4-10 Survival Outcomes in Late, Intermediate and Early Recurrence Renal Cell Carcinoma MP4-11 Surgical Delay After Biopsy and Risk of Upstaging for Clinical T1a Renal Cell Carcinoma MP4-12 Percutaneous Microwave Ablation vs Partial Nephrectomy for Small Renal Masses: Cost-Effectiveness Analysis MP4-13 Characterizing Tumor Thrombus Arising from Non Clear Cell Renal Cell Carcinoma MP4-14 Renal Functional Outcomes after Robotic Assisted Laparoscopic Partial Nephrectomy for Single vs Multiple Renal Tumors MP4-15 Distribution of New Renal Cell Carcinoma Cases Across A Large Statewide Cancer Registry Moderator: Suzanne Merrill, MD 2:00 pm - 2:45 pm 2:45 pm - 3:00 pm Moderator: Sanford Siegel, MD Panelists: Jennifer Miles-Thomas, MD, Matthew Meissner, MD, Ruchika Talwar, MD, Rob Uzzo, MD Moderators: Brant Fulmer, MD, Edouard Trabulsi, MD V-01 Diagnosis and Treatment of Pelvic Organ Prolapse Following Radical Cystectomy V-02 Use of SPY Fluorescent Angiography During Urinary Diversion V-03 Step-by-Step Robotic Ureteral Re-implantation: Intravesical and Extravesical Techniques V-04 Robotic Ureteral Reconstruction for Management of a Recurrent Stricture After Prior Ureterocalicostomy V-05 Intraoperative Management of Incidentally Identified Right Ectopic Ureter Inserting at Bladder Neck During RALP V-06 Combined Robotic and Endoscopic Pyelolithotomy in a Pelvic Kidney V-07 Robotic Assisted Laparoscopic Takedown of an Entero-Ileal Conduit Fistula Moderator: Tracy Krupski, MD Panelists: Jeffery Cadeddu, MD, Mark Ball, MD, Matthew Kaag, MD Moderator: Suzanne Merrill, MD 9:00 am - 9:45 am 9:45 am - 10:00 am Moderators: Joe Littlejohn, MD, Daniel Stein, MD MP5-01 The Effect of 3D Printed Models on Surgical Planning and Outcomes for Partial Nephrectomies MP5-02 Using Resident Evaluators Provides Less Anxiety When Implementing Novel Technical Skills Assessments During Residency Interviews MP5-03 Nephrolithiasis Nutritional Counseling: Comparison of Patient Satisfaction between Face-to-Face and Telehealth Modalities MP5-04 The Utilization of Perfused Cadaver Simulation in Urologic Training MP5-05 Wellness Programming in Urology Residency Programs MP5-06 Difficult Foley? A Look into Difficult Foley Consults MP5-07 The Outcome of Utilizing Robotic Surgical System to Treat Ureteroenteric Anastomotic Stricture MP5-08 Ureteral Stricture Prevention Through a Multi-modal Intervention for Robotic Intracorporeal Ileal Conduit Urinary Diversion MP5-09 HOLEP Perioperative Outcomes Using Three Different Holmium Laser Technologies in a Community Hospital Setting MP5-10 Urology Practice Scores in the Era of the Merit-based Incentive Payment System MP5-11 Telehealth in Urology 1-year into the Pandemic: Sustained Change or a Flash in the Dark MP5-12 The Delayed and Diminished Nephrogram on Computed Tomography: Measurement and Association with Impaired Renal Function MP5-13 Contrast-Enhanced 4D Ultrasonography for the Evaluation of Complex Renal Cysts Moderators: Adam Luchey, MD 10:15 am - 10:30 am 10:30 am - 10:35 am 10:35 am - 10:50 am 10:50 am - 10:55 am 10:55 am - 11:10 am 11:10 am - 11:15 am Moderator: Suzanne Merrill, MD 11:15 am - 11:35 am 11:35 am - 12:00 pm Moderators: Elizabeth T. Brown, MD, MPH, R. Caleb Kovell, MD 1:15 pm - 1:25 pm RPE-01: Diagnostic Dilemmas: A Multi-Institutional Retrospective Analysis of Adrenal Incidentaloma Pathology Based on Radiologic Size 1:25 pm - 1:35 pm RPE-02: Risk of Secondary Malignancies After Pelvic Radiation: A Population-Based Analysis 1:35 pm - 1:45 pm RPE-03: Don’t Skirt the Question: Lead Bed Skirts in the OR, an Intervention 1:45 pm - 1:55 pm RPE-04: Harnessing Choice Architecture in Urologic Practice: Implementation of an Opioid-Sparing Protocol Grounded in Cognitive Behavioral Theory 1:55 pm - 2:05 pm RPE-05: The Impact of COVID-19 on Urologic Surgery Residency and Wellbeing In The US and EU 2:05 pm - 2:15 pm RPE-06: Surgical Preparation in the Next Generation: YouTube Domination? Moderators: Andrew Cohen, MD, Ronak Gor, MD MP6-01 Effects of 2-Years Oral Testosterone Undecanoate (TU) Administration (JATENZO®) on Liver Function and Other Safety Measures in Hypogonadal Men MP6-02 Inflatable Penile Prosthesis Patients Treated with Multimodal Analgesia Have Reduced Risk of Prolonged Opioid Dependence MP6-03 Does A Preemptive Quality of Life Clinic Increase Utilization of Treatment Options Following Radical Prostatectomy? MP6-04 A Comparison of the Psychosocial Impact of Penile Implant and Intracavernosal Injection Therapy for Erectile Dysfunction Using the Self-Esteem and Relationship (SEAR) Questionnaire MP6-05 Patterns Of Surgical Management of Male Stress Urinary Incontinence: Data from the AUA Quality (AQUA) Registry MP6-06 A Comparison of Hospital Charges Between Secondary Robotic Pyeloplasty and Chronic Ureteral Stenting for Management of Recurrent Ureteropelvic Junction Obstruction MP6-07 Surgical Planning for Urethral Reconstruction: Is Retrograde Urethrogram Alone Sufficient MP6-08 General Surgeons’ Comfort and Urologists’ Perceptions of Bladder Trauma Management MP6-09 Multi-Institutional Comparison of Non-Transecting Versus Transecting Primary Robotic Pyeloplasty for Ureteropelvic Junction Obstruction MP6-10 Demucosalized Detrusor Muscle Flaps for Management of Complex Urethral Fistula MP6-11 Robotic Approach for Distal Ureteral Reconstruction in Post-Radiation Ureteral Stricture MP6-12 Effect of Urology Consult on Renal Trauma Outcomes MP6-13 Characterizing the Epidemiology and Management of Urological Trauma in Baltimore, Maryland Moderator: Costas Lallas, MD Panelists: David Chen, MD, Pamela Coleman, MD, Armine Smith, MD Moderator: Jay Raman, MD 3:30 pm - 4:15 pm 4:15 pm - 4:30 pm Moderator: Chad Morley, MD 4:30 pm - 4:42 pm 4:42 pm - 4:45 pm 4:45 pm - 4:57 pm 4:57 pm - 5:00 pm 5:00 pm - 5:12 pm 5:12 pm - 5:15 pm DP-01 DP-02 DP-03 DP-04 DP-05 DP-06 DP-07 DP-08 DP-09 DP-10 DP-11 DP-12 DP-13 DP-14 DP-15 DP-16 DP-17 DP-18 DP-19 DP-20Schedule
Thursday, October 14, 2021
Plenary Session 1: Hugh Hampton Young Lecture
Treatment for Low Testosterone in 2021 - Where Are We Now?
Peter Schlegel, MD
Q&APlenary Session 2: How I Do It – Percutaneous Applications in Urology
US PCNL – How I Do It
Thomas Chi, MD
Q&A
Tubeless PCNL/Mini Perc -outpatient
Michael Byrne, MD
Q&A
Percutaneous Resection of UTUC
John Knoedler, MD
Q&ACONCURRENT SESSION: Moderated Poster Session 1: Prostate Cancer
Keith Kowalczyk
Cheyenne Williams
Benjamin Lowentritt, MD, FACS
Erica Mann, MD
Erica Mann, MD
David Strauss, MD
James Frisbie, MD
Alberto Castro Bigalli, MD, MS
Christopher Herrera
Charles Keith
Daniel Nemirovsky
Isaac Kim, Jr., BSc
Charles Klose, MS
Thenappan Chandrasekar, MD
Ronald Tutrone, MD, FACSPlenary Session 3: A 2021 Update on Male Infertility: Guidelines and Controversies
True: Cori Tanrikut, MD
False: Devang Sharma, MD
Q&A
Tips & Pearls in Clinical Male Infertility: What to Know?
Peter Schlegel, MD
Q&APlenary Session 4: Guest Lecture #1
Post Pandemic Endourology
Thomas Chi, MD
Q&ACONCURRENT SESSION: Moderated Poster Session 2: Stones/Infection/Pediatrics
Meagan Dunne, MD
Katerina Lembrikova
Jason Fairbourn
Samay Sappal, MD
Alex Nourian, MD
Amanda Jones, MD
Rebecca Takele, MS
Jonathan Lim, BSc
Khaled Aldabek
Zachary Werner, MD
Michael Mawhorter, MD
Amanda Seyer, MD, MEd
Meagan Dunne, MDPlenary Session 5: Health Policy Lecture
Evaluating the Impact of Telehealth on Access, Costs and Quality
Chad Ellimoottil, MD
Q&APlenary Session 6: Young Urologist Lecture
If You Want to Make an Important Discovery, Listen to your Patients
Pat Walsh, MD
Q&APlenary Session 7: Resident’s Bowl
Friday, October 15, 2021
Plenary Session 8: Paul Schellhammer Lecturer
Multiparametric MRI to Evaluate Renal Masses – Virtual Biopsy
Jeffrey Cadeddu, MD
Q&APlenary Session 9: Novel Surgical Techniques in Reconstruction in Adults and Pediatrics
Evolution of Robotic Applications in Urologic Reconstruction
Dan Eun, MD
Q&A
Applications and Challenges in Robotics in Pediatric Urology
Arun Srinivasan, MD
Q&A
Robotics in Gender Affirmation Surgery
Ross Krasnow, MD, MPH
Q&ACONCURRENT SESSION: Moderated Poster Session 3: BPH/Urodynamics
Monika Tedeschi, MD
Phillip Huffman
Thomas Mueller, MD
Gregg Eure, MD
Prisca Alilio
Johnathan Drevik, MS, MD
Katerina Lembrikova
Jacques Farhi, MD, MBA
James Liu, MD
Alice Xiang, MD
Tyler Trump, MD
Andrew Higgins, MD
Elizabeth CorleyPlenary Session 10: Innovation in Urinary Incontinence: Implementation & Optimizing Patient Selection
Bulking Agents
Kathleen Kobashi, MD
Implantable PTNS
Ariana Smith, MD
Sacral Neuromodulation
Joe Littlejohn, MD
Q&APlenary Session 11: Telehealth and Billing and Coding in 2021
Telehealth
Jennifer Bepple, MD
Q&A
New CMS
Jonathan Rubenstein, MD
Q&ACONCURRENT SESSION: Moderated Poster Session 4: Kidney/Bladder/Penile/Testicular/Adrenal Cancer
Alberto Castro Bigalli, MD, MS
Alanna Cruz-Bendezu
Tyler Trump, MD
Andrew Salib, MD
Raju Chelluri, MD
Ruchika Talwar, MD
Cyrus Adams-Mardi, MS
Ahmad Alzubaidi, MD
William Visser, MD
Mary Rostom
Leilei Xia, MD
Clinton Yeaman, MD, MS
Matthew Rabinowitz
Srikar Kuppa
Ahmad Alzubaidi, MDPlenary Session 12: Guest Lecture #2
Refractory OAB and What is on the Horizon
Kathleen Kobashi, MD
Q&APlenary Session 13: Panel Discussion: Coaching and Mentoring in Academics/Private Practice
CONCURRENT SESSION: Video Abstracts
Meghan Davis, MD, MPH
Grace Prillaman
Srikar Kuppa
Matthew Lee, MBA
Ahmad Alzubaidi, MD
Andrew Higgins, MD
Daniel Roberson, MDPlenary Session 14: Kidney Cancer Cases – Clinical Case Based Discussion
Saturday, October 16, 2021
Plenary Session 15: AUA Course of Choice
Recurrent UTIs in Women: Ask the Guideline
Jennifer Anger, MD
Q&ACONCURRENT SESSION: Moderated Poster Session 5: Surgical Technology/Imaging
Andrea Quinn
Ahmad Alzubaidi, MD
Kayla Schilling
Daniel McClelland, MD
Haritha Pavuluri, MS
Katharina Mitchell, MD
Ahmad Dahman, MD
Shu Wang, MD
Michael Li, MS
Ridwan Alam, MD, MPH
Ahmad Alzubaidi, MD
Matthew Loecher, MD
Erica MannPlenary Session 16: Current Management in NMIBC
Understanding and Managing BCG Unresponsive Non-muscle Invasive Bladder Cancer
Stephen Boorjian, MD
Q&A
Application of BLC and Novel TUR Techniques
Max Kates, MD
Q&A
Management of Long-Term Complications of Urinary Diversions for NMBIC Necessitating Cystectomy
Minhaj Siddiqui, MD
Q&APlenary Session 17: AUA Guidelines Update
2021 Priapism Guidelines
Trinity Bivalacqua, MD, PhD
2021 Renal Mass (Amendment)
Mohamad Allaf, MDPlenary Session 18: Resident Prize Essay Podium Session
David Zekan, MD
Andrew Salib, MD
Jacob Thatcher, DO
Alex Nourian, MD
Charlotte Goldman, MD
Joshua Eccles, MDCONCURRENT SESSION: Moderated Poster Session 6: Trauma/Sexual Dysfunction
Marc Gittelman, MD
Avery Braun, DO
Paul Prillaman
Andrew Salib, MD
Hasan Dani, MD
Matthew Lee, MBA
Catherine Robey, MA, MD
Joon Yau Leong, MD
David Strauss, MD
Matthew Loecher, MD
Amr Elbakry, MD
Shirley Wang
Isabella PanPlenary Session 19: How I Manage Complications – Case Based Discussion
Plenary Session 20: Guest Lecture #3
Contemporary Surgical Management of High-Risk Prostate Cancer: Pre-, Intra-, and Post-operative Considerations
Stephen Boorjian, MD
Q&APlenary Session 21: Best Papers in 2020 that Changed Your Practice
UTUC
Phil Pierorazio, MD
Q&A
BPH
Steven Sterious, MD
Q&A
Men’s Health
Susan MacDonald, MD
Q&ADisplay Posters - AVAILABLE THROUGHOUT THE MEETING
Persistence of Opioid Reduction Habits 1 Year After Implementation
Andrea Quinn
More Stress or Relief?: Patient Perceptions of Oncologic Follow-up After Surgery for Urologic Malignancies
Sarah Strausser
Concurrent Nephrolithiasis During Partial Nephrectomy: A Multi-Institution Retrospective Analysis of Post-Operative Complications
Andrew Garcia, PharmD
Perioperative Cost Comparison Between Percutaneous Microwave Ablation vs Partial Nephrectomy for Small Renal Masses
Clinton Yeaman, MD, MS
Single Institution Review of Prevena Epidermal Wound Vacuum Usage in Patients undergoing Inguinal Lymph Node Dissection for Penile Cancer
Jacques Farhi, MD, MBA
Decreased Inpatient Opioid Exposure After Robot Prostatectomy with Implementation of Opioid Stewardship Protocols– 2 Year Evaluation from the Pennsylvania Urologic Regional Collaborative (PURC)
Adrien Bernstein, MD
Influence of Patient Clinicopathologic Variables on Prostate Tumor Upgrading at Radical Prostatectomy
Benjamin McSweeney
Active Surveillance or Watchful Waiting in Clinically Low-Risk Prostate Cancer Patients in the SEER Database with and without an Oncotype DX Genomic Prostate Score Assay
Yao Yuan, MPH, PhD
Comparison of Highest-Grade Tumor Percentage in Core Samples from MRI-targeted Biopsy and Systematic Biopsy for Prostate Cancer Diagnosis
Shu Wang, MD
Early Return to Continence Preserved with Suprapubic Catheter Following Retzius-sparing Prostatectomy
Samuel Engelsgjerd, MD
Evaluating Factors Associated with Emergency Department Visits within 30 Days Following Elective Ureteroscopy for Nephrolithiasis
Jennifer Kane
Utilization of Ambulatory Surgery Center and Acute Management Pathway to Improve Stone Treatment Time
Andrew Wang, MD
4 Week Virtual Urology Course Focused on Teaching Non-Urology Students
Andrea Quinn
Trends in Hospital Opioid Use after Urological Trauma
Mary Rostom
Preoperative Predictors of Surgical Success for Robotic Ureteral Reconstruction of Proximal and Middle Ureteral Strictures
Matthew Lee, MBA
Shear Wave Elastography: Novel Methods for the Evaluation of Urethral Stricture Disease
Joon Yau Leong, MD
Utilizing da Vinci ® Robotic Surgical System to treat Distal Ureteral Cancer, Functional and Oncological Outcome
Ahmad Dahman, MD
The Social Impact of Surgery for Nephrolithiasis: Results from the Endourological Society TOWER Research Collaborative
Amanda Jones, MD
Widening of Socioeconomic Disparities After the USPSTF’s 2012 Prostate-Specific Antigen-Based Prostate Cancer Screening Recommendation
Isaac Kim, Jr., MD, PhD, MBA, FACS
Same-Day Discharge and Post-discharge Outcomes after Robot-assisted Radical Prostatectomy
Leilei Xia, MD